Cat. Product Quantity Price Value E0003ge ELISA Kit for Cyclic

Total Page:16

File Type:pdf, Size:1020Kb

Cat. Product Quantity Price Value E0003ge ELISA Kit for Cyclic cat. Product quantity price value E0003Ge ELISA Kit for Cyclic Adenosine Monophosphate(cAMP) 96T 0.067 ng/mL 782 EUR E0248Ge ELISA Kit for Bovine Serum Albumin(BSA) 96T 0.032 ng/mL 782 EUR E0505Ge ELISA Kit for Citrulline(Cit) 96T 0.041 ng/mL 782 EUR E0577Ge ELISA Kit for Cyclic Guanosine Monophosphate(cGMP) 96T 0.032 ng/mL 782 EUR E1002Ge ELISA Kit for 12-Hydroxyeicosatetraenoic Acid(12-HETE) 96T 782 EUR E1434Ge ELISA Kit for Proteinase K(PRK) 96T 0.045 ng/mL 782 EUR E1459Ge ELISA Kit for Ovalbumin(OVA) 96T 0.052 ng/mL 782 EUR E1526Ge ELISA Kit for Lipopolysaccharides(LPS) 96T 0.032 ng/mL 782 EUR E1543Ge ELISA Kit for Mannose(MN) 96T 0.045 ng/mL 782 EUR E1687Ge ELISA Kit for Triglyceride Lipase(TG) 96T 0.057 ng/mL 782 EUR E0152Ge ELISA Kit for Salmon Calcitonin(SCT) 96T 0.13 ng/mL 782 EUR E3051Ge ELISA Kit for Vitamin A(VA) 96T 0.064 ng/mL 782 EUR E3052Ge ELISA Kit for Vitamin K2(VK2) 96T 0.33 ng/mL 782 EUR E3053Ge ELISA Kit for Vitamin B1(VB1) 96T 0.42 ng/mL 782 EUR E3054Ge ELISA Kit for Vitamin B2(VB2) 96T 1.25 ng/mL 782 EUR E3055Ge ELISA Kit for Vitamin B3(VB3) 96T 0.39 nmol/L 782 EUR E3056Ge ELISA Kit for Vitamin B5(VB5) 96T 0.63 U/mL 782 EUR E3057Ge ELISA Kit for 7-Dehydrocholesterol(7-DHC) 96T 0.14 U/mL 782 EUR E3175Ge ELISA Kit for Interferon,Epsilon(IFNe) 96T 0.16 U/mL 782 EUR E3187Ge ELISA Kit for Glucosidase,Alpha;Neutral C(GANC) 96T 0.3U/mL 782 EUR E3188Ge ELISA Kit for Glucosidase,Alpha,Neutral AB(GANAB) 96T 782 EUR E3408Ge ELISA Kit for Gamma Carboxyglutamic Acid(Gla) 96T 0.54 U/mL 782 EUR E3739Ge ELISA Kit for 5-Hydroxyeicosatetraenoic Acid(5-HETE) 96T 15 pg/mL 782 EUR E0001Hu ELISA Kit for Human Activin A(ACV-A) 96T 15 pg/mL 805 EUR E0002Hu ELISA Kit for Human Activated Leukocyte Cell Adhesion Molecule(ALCAM;CD166) 96T 9.6 pg/mL 805 EUR E0004Hu ELISA Kit for Human Angiotensin I Converting Enzyme(ACE;CD143) 96T 16 pg/mL 805 EUR E0005Hu ELISA Kit for Human Angiotensin II(Ang-II) 96T 805 EUR E0006Hu ELISA Kit for Human Amphiregulin(AR) 96T 26 pg/mL 805 EUR E0007Hu ELISA Kit for Human Angiogenin(ANG) 96T 42 pg/mL 805 EUR E0008Hu ELISA Kit for Human Angiopoietin 1(ANG1) 96T 12.8pg/mL 805 EUR E0009Hu ELISA Kit for Human Angiopoietin 2(ANG2) 96T 39pg/mL 805 EUR E0010Hu ELISA Kit for Human Connective Tissue Growth Factor(CTGF) 96T 0.078 ng/mL 805 EUR E0011Hu ELISA Kit for Human Brain Derived Neurotrophic Factor(BDNF) 96T 0.055 ng/mL 805 EUR E0013Hu ELISA Kit for Human Bone Morphogenetic Protein 2(BMP2) 96T 0.04 ng/mL 805 EUR E0014Hu ELISA Kit for Human Bone Morphogenetic Protein 4(BMP4) 96T 0.064ng/mL 805 EUR E0015Hu ELISA Kit for Human Bone Morphogenetic Protein Receptor 1A(BMPR1A;CD292) 96T 0.104 ng/mL 805 EUR E0016Hu ELISA Kit for Human Bone Morphogenetic Protein Receptor II(BMPRII) 96T 0.12 ng/mL 805 EUR E0017Hu ELISA Kit for Human Cadherin,Epithelial(E-Cadherin;CD324) 96T 0.067 ng/mL 805 EUR E0018Hu ELISA Kit for Human Chemokine C-Motif Receptor 1(XCR1) 96T 0.18 ng/mL 805 EUR E0019Hu ELISA Kit for Human Interleukin 8 Receptor Alpha(IL8Ra;CD181) 96T 0.08 ng/mL 805 EUR E0020Hu ELISA Kit for Human Cluster Of Differentiation 33(CD33) 96T 7.5 pg/mL 805 EUR E0021Hu ELISA Kit for Human Ciliary Neurotrophic Factor(CNTF) 96T 27.8 pg/mL 805 EUR E0022Hu ELISA Kit for Human Protein C Receptor,Endothelial(PROCR;CD201) 96T 0.38 ng/mL 805 EUR E0023Hu ELISA Kit for Human Chemokine C-C-Motif Receptor 8(CCR8;CDw198) 96T 10.1 pg/mL 805 EUR E0024Hu ELISA Kit for Human Endocrine Gland Derived Vascular Endothelial Growth Factor(EG-VEGF) 96T 4.5 ng/mL 805 EUR E0025Hu ELISA Kit for Human Eosinophil Chemotactic Factor(ECF;CCL11) 96T 0.4 ng/mL 805 EUR E0026Hu ELISA Kit for Human Chemokine C-C-Motif Ligand 3 Like 1(CCL3L1) 96T 0.15 ng/mL 805 EUR E0027Hu ELISA Kit for Human Erythropoietin Receptor(EPOR) 96T 0.15 ng/mL 805 EUR E0028Hu ELISA Kit for Human Erythropoietin(EPO) 96T 0.58 ng/mL 805 EUR E0029Hu ELISA Kit for Human Selectin,Endothelium(E-Selectin;CD62E) 96T 0.39 ng/mL 805 EUR E0030Hu ELISA Kit for Human Factor Related Apoptosis(FAS;CD95) 96T 0.23 ng/mL 805 EUR E0031Hu ELISA Kit for Human Factor Related Apoptosis Ligand(FASL;CD178) 96T 0.078 ng/mL 805 EUR E0032Hu ELISA Kit for Human Fibroblast Growth Factor 1,Acidic(FGF1) 96T 0.03 ng/mL 805 EUR E0033Hu ELISA Kit for Human Interferon,Alpha(IFNa) 96T 805 EUR E0034Hu ELISA Kit for Human Fibroblast Growth Factor 4(FGF4) 96T 0.07 ng/mL 805 EUR E0035Hu ELISA Kit for Human Fibroblast Growth Factor 6(FGF6) 96T 0.04 ng/mL 805 EUR E0036Hu ELISA Kit for Human Fibroblast Growth Factor 9(FGF9) 96T 805 EUR E0037Hu ELISA Kit for Human Fibronectin(FN) 96T 0.061 ng/mL 805 EUR E0038Hu ELISA Kit for Human FMS Like Tyrosine Kinase 3 Ligand(Flt3L) 96T 11.2 pg/mL 805 EUR E0039Hu ELISA Kit for Human FMS Like Tyrosine Kinase 3(Flt3;CD135) 96T 4.12 pg/mL 805 EUR E0040Hu ELISA Kit for Human Chemokine C-X3-C-Motif Ligand 1(CX3CL1) 96T 3.9 pg/mL 805 EUR E0041Hu ELISA Kit for Human Neutrophil Activating Protein 3(NAP3;CXCL1) 96T 3.6 pg/mL 805 EUR E0042Hu ELISA Kit for Human Colony Stimulating Factor 3,Granulocyte(G-CSF) 96T 11.42 pg/mL 805 EUR E0043Hu ELISA Kit for Human Glial Cell Line Derived Neurotrophic Factor(GDNF) 96T 15.23 pg/mL 805 EUR E0044Hu ELISA Kit for Human Growth Hormone(GH) 96T 3.8 pg/mL 805 EUR E0045Hu ELISA Kit for Human Colony Stimulating Factor 2,Granulocyte Macrophage(GM-CSF) 96T 15.46 pg/mL 805 EUR E0046Hu ELISA Kit for Human Glucoprotein 130(gp130;CD130) 96T 0.078 ng/mL 805 EUR E0047Hu ELISA Kit for Human Hepatocyte Growth Factor(HGF) 96T 0.039 ng/mL 805 EUR E0049Hu ELISA Kit for Human Interferon,Gamma(IFNg) 96T 0.038 ng/mL 805 EUR E0050Hu ELISA Kit for Human Insulin Like Growth Factor 1(IGF1) 96T 0.036 ng/mL 805 EUR E0051Hu ELISA Kit for Human Insulin Like Growth Factor 2(IGF2) 96T 0.076 ng/mL 805 EUR E0052Hu ELISA Kit for Human Insulin Like Growth Factor Binding Protein 1(IGFBP1) 96T 0.12 ng/mL 805 EUR E0053Hu ELISA Kit for Human Insulin Like Growth Factor Binding Protein 2(IGFBP2) 96T 0.16 ng/mL 805 EUR E0054Hu ELISA Kit for Human Insulin Like Growth Factor Binding Protein 3(IGFBP3) 96T 0.034 ng/mL 805 EUR E0055Hu ELISA Kit for Human Insulin Like Growth Factor Binding Protein 4(IGFBP4) 96T 0.18 ng/mL 805 EUR E0056Hu ELISA Kit for Human Interleukin 10(IL10) 96T 0.08 ng/mL 805 EUR E0057Hu ELISA Kit for Human Interleukin 11(IL11) 96T 0.078 ng/mL 805 EUR E0058Hu ELISA Kit for Human Interleukin 12B(IL12B) 96T 0.079 ng/mL 805 EUR E0059Hu ELISA Kit for Human Interleukin 12A(IL12A) 96T 0.076 ng/mL 805 EUR E0060Hu ELISA Kit for Human Interleukin 13(IL13) 96T 0.082 ng/mL 805 EUR E0061Hu ELISA Kit for Human Interleukin 15(IL15) 96T 0.074 ng/mL 805 EUR E0062Hu ELISA Kit for Human Interleukin 16(IL16) 96T 0.16 ng/mL 805 EUR E0063Hu ELISA Kit for Human Interleukin 17(IL17) 96T 7.8 pg/mL 805 EUR E0064Hu ELISA Kit for Human Interleukin 18(IL18) 96T 3.9 pg/mL 805 EUR E0065Hu ELISA Kit for Human Interleukin 1 Receptor Type II(IL1R2;CD121b) 96T 3.8 pg/mL 805 EUR E0066Hu ELISA Kit for Human Interleukin 1 Receptor Type I(IL1R1;CD121a) 96T 3.5 pg/mL 805 EUR E0067Hu ELISA Kit for Human Cortisone(COR) 96T 7.6 pg/mL 805 EUR E0068Hu ELISA Kit for Human Glial Fibrillary Acidic Protein(GFAP) 96T 11.72 pg/mL 805 EUR E0069Hu ELISA Kit for Human N-Acetyl Beta D Glucosaminidase(NAGase) 96T 15.6 pg/mL 805 EUR E0070Hu ELISA Kit for Human Androsterone(ADT) 96T 3.6 pg/mL 805 EUR E0071Hu ELISA Kit for Human Interleukin 1 Alpha(IL1a) 96T 15.8 pg/mL 805 EUR E0073Hu ELISA Kit for Human Interleukin 2(IL2) 96T 805 EUR E0076Hu ELISA Kit for Human Interleukin 3(IL3) 96T 805 EUR E0077Hu ELISA Kit for Human Interleukin 4(IL4) 96T 805 EUR E0078Hu ELISA Kit for Human Interleukin 5(IL5) 96T 805 EUR E0079Hu ELISA Kit for Human Interleukin 6(IL6) 96T 805 EUR E0080Hu ELISA Kit for Human Interleukin 8(IL8;CXCL8) 96T 805 EUR E0081Hu ELISA Kit for Human Interleukin 9(IL9) 96T 805 EUR E0082Hu ELISA Kit for Human Laminin Beta 1(LAMb1) 96T 0.16 ng/mL 805 EUR E0083Hu ELISA Kit for Human Leptin Receptor(LEPR;CD295) 96T 0.078 ng/mL 805 EUR E0084Hu ELISA Kit for Human Leptin(LEP) 96T 0.079 ng/mL 805 EUR E0085Hu ELISA Kit for Human Leukemia Inhibitory Factor(LIF) 96T 0.195 ng/mL 805 EUR E0086Hu ELISA Kit for Human Selectin;Leukocyte(L-Selectin;CD62L) 96T 0.23 ng/mL 805 EUR E0087Hu ELISA Kit for Human Monocyte Chemotactic Protein 1(MCP1;CCL2) 96T 0.076 ng/mL 805 EUR E0088Hu ELISA Kit for Human Monocyte Chemotactic Protein 2(MCP2;CCL8) 96T 805 EUR E0089Hu ELISA Kit for Human Monocyte Chemotactic Protein 3(MCP3;CCL7) 96T 805 EUR E0090Hu ELISA Kit for Human Colony Stimulating Factor 1,Macrophage(M-CSF) 96T 805 EUR E0091Hu ELISA Kit for Human Macrophage Derived Chemokine(MDC;CCL22) 96T 0.12 ng/mL 805 EUR E0092Hu ELISA Kit for Human Macrophage Inflammatory Protein 1 Alpha(MIP1a;CCL3) 96T 0.04 ng/mL 805 EUR E0093Hu ELISA Kit for Human Macrophage Inflammatory Protein 1 Beta(MIP1b;CCL4) 96T 805 EUR E0094Hu ELISA Kit for Human Caspase 11(CASP11) 96T 0.039 ng/mL 805 EUR E0095Hu ELISA Kit for Human Macrophage Inflammatory Protein 3 Alpha(MIP3a;CCL20) 96T 0.116 ng/mL 805 EUR E0096Hu ELISA Kit for Human Macrophage Inflammatory Protein 3 Beta(MIP3b;CCL19) 96T 805 EUR E0097Hu ELISA Kit for Human Matrix Metalloproteinase 1(MMP1) 96T 805 EUR E0098Hu ELISA Kit for Human Matrix Metalloproteinase 10(MMP10) 96T 15.6 pg/mL 805 EUR E0099Hu ELISA Kit for Human Matrix Metalloproteinase 13(MMP13) 96T 10 pg/mL 805 EUR E0100Hu ELISA Kit for Human Matrix Metalloproteinase 2(MMP2) 96T 9.6 pg/mL 805 EUR E0101Hu ELISA Kit for Human Matrix Metalloproteinase 3(MMP3) 96T 11.72 pg/mL 805 EUR E0102Hu ELISA Kit for Human Matrix Metalloproteinase 7(MMP7) 96T 19.5 pg/mL 805 EUR E0103Hu
Recommended publications
  • Imm Catalog.Pdf
    $ Gene Symbol A B 3 C 4 D 9 E 10 F 11 G 12 H 13 I 14 J. K 17 L 18 M 19 N 20 O. P 22 R 26 S 27 T 30 U 32 V. W. X. Y. Z 33 A ® ® Gene Symbol Gene ID Antibody Monoclonal Antibody Polyclonal MaxPab Full-length Protein Partial-length Protein Antibody Pair KIt siRNA/Chimera Gene Symbol Gene ID Antibody Monoclonal Antibody Polyclonal MaxPab Full-length Protein Partial-length Protein Antibody Pair KIt siRNA/Chimera A1CF 29974 ● ● ADAMTS13 11093 ● ● ● ● ● A2M 2 ● ● ● ● ● ● ADAMTS20 80070 ● AACS 65985 ● ● ● ADAMTS5 11096 ● ● ● AANAT 15 ● ● ADAMTS8 11095 ● ● ● ● AATF 26574 ● ● ● ● ● ADAMTSL2 9719 ● AATK 9625 ● ● ● ● ADAMTSL4 54507 ● ● ABCA1 19 ● ● ● ● ● ADAR 103 ● ● ABCA5 23461 ● ● ADARB1 104 ● ● ● ● ABCA7 10347 ● ADARB2 105 ● ABCB9 23457 ● ● ● ● ● ADAT1 23536 ● ● ABCC4 10257 ● ● ● ● ADAT2 134637 ● ● ABCC5 10057 ● ● ● ● ● ADAT3 113179 ● ● ● ABCC8 6833 ● ● ● ● ADCY10 55811 ● ● ABCD2 225 ● ADD1 118 ● ● ● ● ● ● ABCD4 5826 ● ● ● ADD3 120 ● ● ● ABCG1 9619 ● ● ● ● ● ADH5 128 ● ● ● ● ● ● ABL1 25 ● ● ADIPOQ 9370 ● ● ● ● ● ABL2 27 ● ● ● ● ● ADK 132 ● ● ● ● ● ABO 28 ● ● ADM 133 ● ● ● ABP1 26 ● ● ● ● ● ADNP 23394 ● ● ● ● ABR 29 ● ● ● ● ● ADORA1 134 ● ● ACAA2 10449 ● ● ● ● ADORA2A 135 ● ● ● ● ● ● ● ACAN 176 ● ● ● ● ● ● ADORA2B 136 ● ● ACE 1636 ● ● ● ● ADRA1A 148 ● ● ● ● ACE2 59272 ● ● ADRA1B 147 ● ● ACER2 340485 ● ADRA2A 150 ● ● ACHE 43 ● ● ● ● ● ● ADRB1 153 ● ● ACIN1 22985 ● ● ● ADRB2 154 ● ● ● ● ● ACOX1 51 ● ● ● ● ● ADRB3 155 ● ● ● ● ACP5 54 ● ● ● ● ● ● ● ADRBK1 156 ● ● ● ● ACSF2 80221 ● ● ADRM1 11047 ● ● ● ● ACSF3 197322 ● ● AEBP1 165 ● ● ● ● ACSL4 2182 ●
    [Show full text]
  • Enzymatic Encoding Methods for Efficient Synthesis Of
    (19) TZZ__T (11) EP 1 957 644 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C12N 15/10 (2006.01) C12Q 1/68 (2006.01) 01.12.2010 Bulletin 2010/48 C40B 40/06 (2006.01) C40B 50/06 (2006.01) (21) Application number: 06818144.5 (86) International application number: PCT/DK2006/000685 (22) Date of filing: 01.12.2006 (87) International publication number: WO 2007/062664 (07.06.2007 Gazette 2007/23) (54) ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES ENZYMVERMITTELNDE KODIERUNGSMETHODEN FÜR EINE EFFIZIENTE SYNTHESE VON GROSSEN BIBLIOTHEKEN PROCEDES DE CODAGE ENZYMATIQUE DESTINES A LA SYNTHESE EFFICACE DE BIBLIOTHEQUES IMPORTANTES (84) Designated Contracting States: • GOLDBECH, Anne AT BE BG CH CY CZ DE DK EE ES FI FR GB GR DK-2200 Copenhagen N (DK) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • DE LEON, Daen SK TR DK-2300 Copenhagen S (DK) Designated Extension States: • KALDOR, Ditte Kievsmose AL BA HR MK RS DK-2880 Bagsvaerd (DK) • SLØK, Frank Abilgaard (30) Priority: 01.12.2005 DK 200501704 DK-3450 Allerød (DK) 02.12.2005 US 741490 P • HUSEMOEN, Birgitte Nystrup DK-2500 Valby (DK) (43) Date of publication of application: • DOLBERG, Johannes 20.08.2008 Bulletin 2008/34 DK-1674 Copenhagen V (DK) • JENSEN, Kim Birkebæk (73) Proprietor: Nuevolution A/S DK-2610 Rødovre (DK) 2100 Copenhagen 0 (DK) • PETERSEN, Lene DK-2100 Copenhagen Ø (DK) (72) Inventors: • NØRREGAARD-MADSEN, Mads • FRANCH, Thomas DK-3460 Birkerød (DK) DK-3070 Snekkersten (DK) • GODSKESEN,
    [Show full text]
  • Cleveland Clinic Laboratories
    Cleveland Clinic Laboratories Technical Update • May 2014 Cleveland Clinic Laboratories is dedicated to keeping you updated and informed about recent testing changes. That's why we are happy to provide this technical update on a monthly basis. Recently changed tests are bolded, and could include revisions to methodology, reference range, days performed or CPT code. For your convenience, tests are listed alphabetically and the order and billing codes are provided. If you wish to compare the new information with previous test demographics, refer to the Test Directory, which can be accessed at clevelandcliniclabs.com. Deleted tests and new tests are listed separately. Please update your database as necessary. For additional detail, contact Client Services at 216.444.5755 or 800.628.6816 or via email at [email protected]. Days Performed/Reported Specimen Requirement Special InformationComponent Change Test Discontinued Reference Range Test Update Name Change Methodology Order CodeBiling Code New Test Page # Summary of Changes CPT by Test Name 3 5-Hydroxyindolacetic Acid, Urine 3 11-Deoxycorticosterone Qt, Serum / Plasma 3 25-Hydroxyvitamin D2 and D3, Serum 9 Alpha-1 Antitrypsin (SERPINA1) Targeted Genotyping 3 Alpha-1-Antitrypsin Clearance 3 Alpha-1-Antitrypsin, Stool 3 Anti IgA Antibody 3 Anti Mullerian Hormone 3 Beta Galactosidase, Leukocytes 4 Bioavailable Testosterone / SHBG, Female & Child 4 BK Virus Quantitation, Urine 12 Buprenorphine & Metabolite, Confirmation / Quant, Urine 9 Buprenorphine Quant, Urine 4 Carnitine Free & Total,
    [Show full text]
  • PROTEOMIC ANALYSIS of HUMAN URINARY EXOSOMES. Patricia
    ABSTRACT Title of Document: PROTEOMIC ANALYSIS OF HUMAN URINARY EXOSOMES. Patricia Amalia Gonzales Mancilla, Ph.D., 2009 Directed By: Associate Professor Nam Sun Wang, Department of Chemical and Biomolecular Engineering Exosomes originate as the internal vesicles of multivesicular bodies (MVBs) in cells. These small vesicles (40-100 nm) have been shown to be secreted by most cell types throughout the body. In the kidney, urinary exosomes are released to the urine by fusion of the outer membrane of the MVBs with the apical plasma membrane of renal tubular epithelia. Exosomes contain apical membrane and cytosolic proteins and can be isolated using differential centrifugation. The analysis of urinary exosomes provides a non- invasive means of acquiring information about the physiological or pathophysiological state of renal cells. The overall objective of this research was to develop methods and knowledge infrastructure for urinary proteomics. We proposed to conduct a proteomic analysis of human urinary exosomes. The first objective was to profile the proteome of human urinary exosomes using liquid chromatography-tandem spectrometry (LC- MS/MS) and specialized software for identification of peptide sequences from fragmentation spectra. We unambiguously identified 1132 proteins. In addition, the phosphoproteome of human urinary exosomes was profiled using the neutral loss scanning acquisition mode of LC-MS/MS. The phosphoproteomic profiling identified 19 phosphorylation sites corresponding to 14 phosphoproteins. The second objective was to analyze urinary exosomes samples isolated from patients with genetic mutations. Polyclonal antibodies were generated to recognize epitopes on the gene products of these genetic mutations, NKCC2 and MRP4. The potential usefulness of urinary exosome analysis was demonstrated using the well-defined renal tubulopathy, Bartter syndrome type I and using the single nucleotide polymorphism in the ABCC4 gene.
    [Show full text]
  • N-Glycan Trimming in the ER and Calnexin/Calreticulin Cycle
    Neurotransmitter receptorsGABA and A postsynapticreceptor activation signal transmission Ligand-gated ion channel transport GABAGABA Areceptor receptor alpha-5 alpha-1/beta-1/gamma-2 subunit GABA A receptor alpha-2/beta-2/gamma-2GABA receptor alpha-4 subunit GABAGABA receptor A receptor beta-3 subunitalpha-6/beta-2/gamma-2 GABA-AGABA receptor; A receptor alpha-1/beta-2/gamma-2GABA receptoralpha-3/beta-2/gamma-2 alpha-3 subunit GABA-A GABAreceptor; receptor benzodiazepine alpha-6 subunit site GABA-AGABA-A receptor; receptor; GABA-A anion site channel (alpha1/beta2 interface) GABA-A receptor;GABA alpha-6/beta-3/gamma-2 receptor beta-2 subunit GABAGABA receptorGABA-A receptor alpha-2receptor; alpha-1 subunit agonist subunit GABA site Serotonin 3a (5-HT3a) receptor GABA receptorGABA-C rho-1 subunitreceptor GlycineSerotonin receptor subunit3 (5-HT3) alpha-1 receptor GABA receptor rho-2 subunit GlycineGlycine receptor receptor subunit subunit alpha-2 alpha-3 Ca2+ activated K+ channels Metabolism of ingested SeMet, Sec, MeSec into H2Se SmallIntermediateSmall conductance conductance conductance calcium-activated calcium-activated calcium-activated potassium potassium potassiumchannel channel protein channel protein 2 protein 1 4 Small conductance calcium-activatedCalcium-activated potassium potassium channel alpha/beta channel 1 protein 3 Calcium-activated potassiumHistamine channel subunit alpha-1 N-methyltransferase Neuraminidase Pyrimidine biosynthesis Nicotinamide N-methyltransferase Adenosylhomocysteinase PolymerasePolymeraseHistidine basic
    [Show full text]
  • Genes in Eyecare Geneseyedoc 3 W.M
    Genes in Eyecare geneseyedoc 3 W.M. Lyle and T.D. Williams 15 Mar 04 This information has been gathered from several sources; however, the principal source is V. A. McKusick’s Mendelian Inheritance in Man on CD-ROM. Baltimore, Johns Hopkins University Press, 1998. Other sources include McKusick’s, Mendelian Inheritance in Man. Catalogs of Human Genes and Genetic Disorders. Baltimore. Johns Hopkins University Press 1998 (12th edition). http://www.ncbi.nlm.nih.gov/Omim See also S.P.Daiger, L.S. Sullivan, and B.J.F. Rossiter Ret Net http://www.sph.uth.tmc.edu/Retnet disease.htm/. Also E.I. Traboulsi’s, Genetic Diseases of the Eye, New York, Oxford University Press, 1998. And Genetics in Primary Eyecare and Clinical Medicine by M.R. Seashore and R.S.Wappner, Appleton and Lange 1996. M. Ridley’s book Genome published in 2000 by Perennial provides additional information. Ridley estimates that we have 60,000 to 80,000 genes. See also R.M. Henig’s book The Monk in the Garden: The Lost and Found Genius of Gregor Mendel, published by Houghton Mifflin in 2001 which tells about the Father of Genetics. The 3rd edition of F. H. Roy’s book Ocular Syndromes and Systemic Diseases published by Lippincott Williams & Wilkins in 2002 facilitates differential diagnosis. Additional information is provided in D. Pavan-Langston’s Manual of Ocular Diagnosis and Therapy (5th edition) published by Lippincott Williams & Wilkins in 2002. M.A. Foote wrote Basic Human Genetics for Medical Writers in the AMWA Journal 2002;17:7-17. A compilation such as this might suggest that one gene = one disease.
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • Pancancer Progression Human Vjune2017
    Gene Symbol Accession Alias/Prev Symbol Official Full Name AAMP NM_001087.3 - angio-associated, migratory cell protein ABI3BP NM_015429.3 NESHBP|TARSH ABI family, member 3 (NESH) binding protein ACHE NM_000665.3 ACEE|ARACHE|N-ACHE|YT acetylcholinesterase ACTG2 NM_001615.3 ACT|ACTA3|ACTE|ACTL3|ACTSG actin, gamma 2, smooth muscle, enteric ACVR1 NM_001105.2 ACTRI|ACVR1A|ACVRLK2|ALK2|FOP|SKR1|TSRI activin A receptor, type I ACVR1C NM_145259.2 ACVRLK7|ALK7 activin A receptor, type IC ACVRL1 NM_000020.1 ACVRLK1|ALK-1|ALK1|HHT|HHT2|ORW2|SKR3|TSR-I activin A receptor type II-like 1 ADAM15 NM_207195.1 MDC15 ADAM metallopeptidase domain 15 ADAM17 NM_003183.4 ADAM18|CD156B|CSVP|NISBD|TACE ADAM metallopeptidase domain 17 ADAM28 NM_014265.4 ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII ADAM metallopeptidase domain 28 ADAM8 NM_001109.4 CD156|MS2 ADAM metallopeptidase domain 8 ADAM9 NM_001005845.1 CORD9|MCMP|MDC9|Mltng ADAM metallopeptidase domain 9 ADAMTS1 NM_006988.3 C3-C5|METH1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 ADAMTS12 NM_030955.2 PRO4389 ADAM metallopeptidase with thrombospondin type 1 motif, 12 ADAMTS8 NM_007037.4 ADAM-TS8|METH2 ADAM metallopeptidase with thrombospondin type 1 motif, 8 ADAP1 NM_006869.2 CENTA1|GCS1L|p42IP4 ArfGAP with dual PH domains 1 ADD1 NM_001119.4 ADDA adducin 1 (alpha) ADM2 NM_001253845.1 AM2|dJ579N16.4 adrenomedullin 2 ADRA2B NM_000682.4 ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR adrenoceptor alpha 2B AEBP1 NM_001129.3 ACLP AE binding protein 1 AGGF1 NM_018046.3 GPATC7|GPATCH7|HSU84971|HUS84971|VG5Q
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Cloud-Clone 16-17
    Cloud-Clone - 2016-17 Catalog Description Pack Size Supplier Rupee(RS) ACB028Hu CLIA Kit for Anti-Albumin Antibody (AAA) 96T Cloud-Clone 74750 AEA044Hu ELISA Kit for Anti-Growth Hormone Antibody (Anti-GHAb) 96T Cloud-Clone 74750 AEA255Hu ELISA Kit for Anti-Apolipoprotein Antibodies (AAHA) 96T Cloud-Clone 74750 AEA417Hu ELISA Kit for Anti-Proteolipid Protein 1, Myelin Antibody (Anti-PLP1) 96T Cloud-Clone 74750 AEA421Hu ELISA Kit for Anti-Myelin Oligodendrocyte Glycoprotein Antibody (Anti- 96T Cloud-Clone 74750 MOG) AEA465Hu ELISA Kit for Anti-Sperm Antibody (AsAb) 96T Cloud-Clone 74750 AEA539Hu ELISA Kit for Anti-Myelin Basic Protein Antibody (Anti-MBP) 96T Cloud-Clone 71250 AEA546Hu ELISA Kit for Anti-IgA Antibody 96T Cloud-Clone 71250 AEA601Hu ELISA Kit for Anti-Myeloperoxidase Antibody (Anti-MPO) 96T Cloud-Clone 71250 AEA747Hu ELISA Kit for Anti-Complement 1q Antibody (Anti-C1q) 96T Cloud-Clone 74750 AEA821Hu ELISA Kit for Anti-C Reactive Protein Antibody (Anti-CRP) 96T Cloud-Clone 74750 AEA895Hu ELISA Kit for Anti-Insulin Receptor Antibody (AIRA) 96T Cloud-Clone 74750 AEB028Hu ELISA Kit for Anti-Albumin Antibody (AAA) 96T Cloud-Clone 71250 AEB264Hu ELISA Kit for Insulin Autoantibody (IAA) 96T Cloud-Clone 74750 AEB480Hu ELISA Kit for Anti-Mannose Binding Lectin Antibody (Anti-MBL) 96T Cloud-Clone 88575 AED245Hu ELISA Kit for Anti-Glutamic Acid Decarboxylase Antibodies (Anti-GAD) 96T Cloud-Clone 71250 AEK505Hu ELISA Kit for Anti-Heparin/Platelet Factor 4 Antibodies (Anti-HPF4) 96T Cloud-Clone 71250 CCA005Hu CLIA Kit for Angiotensin II
    [Show full text]
  • GPCR Expression in Cancer Cells and Tumors Identifies New
    fphar-09-00431 May 17, 2018 Time: 16:38 # 1 ORIGINAL RESEARCH published: 22 May 2018 doi: 10.3389/fphar.2018.00431 GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets Paul A. Insel1,2*†, Krishna Sriram1†, Shu Z. Wiley1, Andrea Wilderman1, Trishna Katakia1, Thalia McCann1, Hiroshi Yokouchi1, Lingzhi Zhang1, Ross Corriden1, Dongling Liu1, Michael E. Feigin3, Randall P. French4,5, Andrew M. Lowy4,5 and Fiona Murray1,2,6† 1 Department of Pharmacology, University of California, San Diego, San Diego, CA, United States, 2 Department of Medicine, University of California, San Diego, San Diego, CA, United States, 3 Department of Pharmacology and Therapeutics, Roswell Edited by: Park Comprehensive Cancer Center, Buffalo, NY, United States, 4 Department of Surgery, University of California, San Diego, Ramaswamy Krishnan, San Diego, CA, United States, 5 Moores Cancer Center, University of California, San Diego, San Diego, CA, United States, Harvard Medical School, 6 School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom United States Reviewed by: G protein-coupled receptors (GPCRs), the largest family of targets for approved drugs, Kevin D. G. Pfleger, Harry Perkins Institute of Medical are rarely targeted for cancer treatment, except for certain endocrine and hormone- Research, Australia responsive tumors. Limited knowledge regarding GPCR expression in cancer cells likely Deepak A. Deshpande, has contributed to this lack of use of GPCR-targeted drugs as cancer therapeutics. Thomas Jefferson University, United States We thus undertook GPCRomic studies to define the expression of endoGPCRs *Correspondence: (which respond to endogenous molecules such as hormones, neurotransmitters and Paul A.
    [Show full text]
  • Supplementary Materials
    Supplementary material. S1. Images from automatic imaging reader Cytation™ 1. A, A’, A’’ present the same field of view. Cells migrating from the upper compartment of the inserts are stained with DID (red color), Cell nuclei are stained with DAPI (blue color). A’ and A’’ demonstrate the method of analysis (A’ – nuclei numbering, A’’ – migrating cells numbering), scale bar – 300 µm. ASC BM-MSC Y BM-MSC A mean SEM mean SEM mean SEM CXCL6 2.240 0.727 4.158 0.677 2.149 1.816 CXCL16 4.277 0.248 0.763 0.405 1.130 0.346 CXCL12 -2.855 0.483 -4.528 0.226 -3.616 0.318 SMAD3 -0.511 0.191 -1.522 0.188 -1.332 0.215 TGFB2 3.742 0.533 1.238 0.210 0.990 0.568 COL14A 1.532 0.357 -0.397 0.736 -1.522 0.469 MHX 1.397 0.414 1.145 0.412 0.642 0.613 SCX 2.984 0.301 2.062 0.320 2.031 0.249 RUNX2 3.290 0.359 2.319 0.388 2.546 0.529 PPRAG 1.720 0.303 2.926 0.423 2.912 0.215 Supplementary material S3. The table provides the mean Δct and SEM values for all genes and all groups analyzed in this study (n=8 in each group). Supplementary material S2. The table provides the list of genes which displayed significantly different expression between hASCs and hBM-MSCs A based on microarray nr Exp p-value Exp Fold Change ID Symbol Entrez Gene Name 1 2.84E-05 16.896 16960355 TM4SF1 transmembrane 4 L six family member 1 2 9.10E-09 12.238 16684080 IFI6 interferon alpha inducible protein 6 3 3.93E-08 11.851 16667702 VCAM1 vascular cell adhesion molecule 1 4 1.54E-05 9.944 16840113 CXCL16 C-X-C motif chemokine ligand 16 5 2.01E-06 9.123 16852463 RAB27B RAB27B, member RAS oncogene
    [Show full text]